
TSE:JWEL
This summary was created by AI, based on 2 opinions in the last 12 months.
Jamieson Wellness, a Windsor ON-based company, has gained prominence in the market due to its strategic acquisitions and expansion into international markets like China. With a strong focus on quality, the company has differentiated itself from competitors, making it a sought-after investment for those looking to bolster their portfolios. Analysts suggest that the stock has a positive trajectory, supported by a consistent 14% dividend growth over the past five years and a current yield of 2.55%. Additionally, the stock is seen as a good performer following a recovery from its 2023 low, showing a defined uptrend characterized by higher highs and higher lows. The consensus price target of $42.43 indicates confidence in the stock's potential for future growth.
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. EPS at 34 cents that beat estimates by 2%. Sales of $112.3M were reported. Generally a good quarter. The focus on post covid health trends continue to be a tailwind. Attractive here. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues beat street estimates by 4%. EBITDA was 2% better at $29M. It is trading at 26x earnings, which is reasonably considering the high growth expectations. There are competitors but they have strong market share. A higher risk buy for growth and some income. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Business has reamiend good and earnings growth continues to be expected. They raised dividends in August with more room to grow. The $6 decline is probably over done. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales beat expectations by 6% and earnings also beat estimates by 2%. Guidance was raised, which is also positive. The pull back that brought it down 16% is more market related than to do with the stock itself. It is a good time to add to this position. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Covid has helped the company with consumers more aware of health. They beat sale estimates last quarter but missed on EPS. It’s trading within its expected growth rate. The health trend should be sustained even after covid. Unlock Premium - Try 5i Free